Kanegafuchi Chemical Industry Co., Ltd. – Trademark Portfolio
Entity Type: 03
Kanegafuchi Chemical Industry Co., Ltd. holds 11 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 6 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 4 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include ELMECH, SULFLUX, LIPOSORBER, and KANEKA TELALLOY. The owner is based in Kita-ku, Osaka.
2-4, Nakanoshima 3-chome
Kita-ku, Osaka , JP
Showing of trademarks Trademarks
Trademark Classifications
Kanegafuchi Chemical Industry Co., Ltd.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Frequently Asked Questions
How many trademarks does Kanegafuchi Chemical Industry Co., Ltd. have?
Kanegafuchi Chemical Industry Co., Ltd. has 11 U.S. trademarks filed with the USPTO. Of these, 4 registered, 1 abandoned, 6 cancelled.
What trademark classes does Kanegafuchi Chemical Industry Co., Ltd. file in?
Kanegafuchi Chemical Industry Co., Ltd. files trademarks across 4 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 10 (Medical Apparatus), Class 31 (Natural Agricultural Products), Class 17 (Rubber Goods). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are Kanegafuchi Chemical Industry Co., Ltd.'s most well-known trademarks?
Kanegafuchi Chemical Industry Co., Ltd.'s registered trademark portfolio includes well-known marks such as ELMECH, SULFLUX, LIPOSORBER, and KANEKA TELALLOY. These are among 4 currently registered trademarks in the portfolio.
What is Kanegafuchi Chemical Industry Co., Ltd.'s trademark registration success rate?
Kanegafuchi Chemical Industry Co., Ltd. has a 36% trademark registration rate, with 4 out of 11 resolved applications resulting in successful registration. Currently, 0 applications are pending review.